Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in?vitro models of hepatic metabolism.
Law R, Lewis D, Hain D, Daut R, DelBello MP, Frazier JA, Newcorn JH, Nurmi E, Cogan ES, Wagner S, Johnson H, Lanchbury J. Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in?vitro models of hepatic metabolism. Xenobiotica. 2022 Jul; 52(7):676-686.